Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Population-based screening to prevent colorectal cancer (CRC) death is effective, but the effectiveness of postpolypectomy surveillance is unclear. OBJECTIVE: To evaluate the additional benefit in terms of cost-effectiveness of colonoscopy surveillance in a screening setting. DESIGN: Microsimulation using the ASCCA (Adenoma and Serrated pathway to Colorectal CAncer) model. DATA SOURCES: Dutch CRC screening program and published literature. TARGET POPULATION: Asymptomatic persons aged 55 to 75 years without a prior CRC diagnosis. TIME HORIZON: Lifetime. PERSPECTIVE: Health care payer. INTERVENTION: Fecal immunochemical test (FIT) screening with colonoscopy surveillance performed according to the Dutch guideline was simulated. The comparator was no screening or surveillance. FIT screening without colonoscopy surveillance and the effect of extending surveillance intervals were also evaluated. OUTCOME MEASURES: CRC burden, colonoscopy demand, life-years, and costs. RESULTS OF BASE-CASE ANALYSIS: FIT screening without surveillance reduced CRC mortality by 50.4% compared with no screening or surveillance. Adding surveillance to FIT screening reduced mortality by an additional 1.7% to 52.1% but increased lifetime colonoscopy demand by 62% (from 335 to 543 colonoscopies per 1000 persons) at an additional cost of €68 000, for an increase of 0.9 life-year. Extending the surveillance intervals to 5 years reduced CRC mortality by 51.8% and increased colonoscopy demand by 42.7% compared with FIT screening without surveillance. In an incremental analysis, incremental cost-effectiveness ratios (ICERs) for screening plus surveillance exceeded the Dutch willingness-to-pay threshold of €36 602 per life-year gained. RESULTS OF SENSITIVITY ANALYSIS: When using a parameter set representing low colorectal lesion prevalence or when colonoscopy costs were halved or colorectal lesion incidence was doubled, screening plus surveillance became cost-effective compared with screening without surveillance. LIMITATION: Limited data on FIT performance and background CRC risk in the surveillance population. CONCLUSION: Adding surveillance to FIT screening is not cost-effective based on the Dutch ICER threshold and substantially increases colonoscopy demand. Extending surveillance intervals to 5 years would decrease colonoscopy demand without substantial loss of effectiveness. PRIMARY FUNDING SOURCE: Alpe d'HuZes, Dutch Cancer Society, and Stand Up To Cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sanders, G. D., Neumann, P. J., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.12195 · Cited by 3,069
Siegel, J. E., Torrance, G. W., Russell, L. B., Luce, B. R., Weinstein, M. C., & Gold, M. R. (1997) · PharmacoEconomics · doi:10.2165/00019053-199711020-00005 · Cited by 233
Cited by
Gupta, S., Lieberman, D., Anderson, J. C., Burke, C. A., Dominitz, J. A., Kaltenbach, T., Robertson, D. J., Shaukat, A., Syngal, S., & Rex, D. K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.10.026 · Cited by 461
Gupta, S., Lieberman, D., Anderson, J. C., Burke, C. A., Dominitz, J. A., Kaltenbach, T., Robertson, D. J., Shaukat, A., Syngal, S., & Rex, D. K. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000544 · Cited by 343
Gupta, S., Lieberman, D., Anderson, J. C., Burke, C. A., Dominitz, J. A., Kaltenbach, T., Robertson, D. J., Shaukat, A., Syngal, S., & Rex, D. K. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.01.014 · Cited by 325
Atkin, W., Cross, A. J., Kralj-Hans, I., MacRae, E., Piggott, C., Pearson, S., Wooldrage, K., Brown, J., Lucas, F., Prendergast, A., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23010 · Cited by 129
Artificial Intelligence Allows Leaving-In-Situ Colorectal Polyps
Hassan, C., Balsamo, G., Lorenzetti, R., Zullo, A., & Antonelli, G. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.04.045 · Cited by 119
Metadata
- Authors
- Greuter, M. J. E., de Klerk, C. M., Meijer, G. A., Dekker, E., & Coupé, V. M. H.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2017-10-17
- Volume
- 167
- Issue
- 8
- Pages
- 544-554
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2764295328
- Cited by
- 64
- References
- 2
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis. https://app.cochat.ai/papers/10.7326/m16-2891
- The paper
- Greuter, M. J. E., de Klerk, C. M., Meijer, G. A., Dekker, E., & Coupé, V. M. H. (2017). Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis. Annals of Internal Medicine. https://doi.org/10.7326/m16-2891
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.